Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

79 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Dose-ranging study of indole-3-carbinol for breast cancer prevention.
Wong GY, Bradlow L, Sepkovic D, Mehl S, Mailman J, Osborne MP. Wong GY, et al. J Cell Biochem Suppl. 1997;28-29:111-6. doi: 10.1002/(sici)1097-4644(1997)28/29+<111::aid-jcb12>3.0.co;2-k. J Cell Biochem Suppl. 1997. PMID: 9589355 Clinical Trial.
Phytochemicals as modulators of cancer risk.
Bradlow HL, Telang NT, Sepkovic DW, Osborne MP. Bradlow HL, et al. Adv Exp Med Biol. 1999;472:207-21. doi: 10.1007/978-1-4757-3230-6_18. Adv Exp Med Biol. 1999. PMID: 10736628 Review.
Multifunctional aspects of the action of indole-3-carbinol as an antitumor agent.
Bradlow HL, Sepkovic DW, Telang NT, Osborne MP. Bradlow HL, et al. Ann N Y Acad Sci. 1999;889:204-13. doi: 10.1111/j.1749-6632.1999.tb08736.x. Ann N Y Acad Sci. 1999. PMID: 10668495 Review.
In addition to these indirect effects as a result of altered estrogen metabolism, indole-3-carbinol has been shown to have direct effects on apoptosis and cyclin D, resulting in blockage of the cell cycle. ...
In addition to these indirect effects as a result of altered estrogen metabolism, indole-3-carbinol has been shown to have direct effects on …
Quantitative determination of 3,3'-diindolylmethane in urine of individuals receiving indole-3-carbinol.
Sepkovic DW, Bradlow HL, Bell M. Sepkovic DW, et al. Nutr Cancer. 2001;41(1-2):57-63. doi: 10.1080/01635581.2001.9680612. Nutr Cancer. 2001. PMID: 12094629
I3C significantly inhibits the cell adhesion, spreading, and invasion associated with an upregulation of PTEN (a tumor suppressor gene) and E-cadherin (a regulator of cell-cell adhesion) expression in T47-D human breast cancer cells. ...
I3C significantly inhibits the cell adhesion, spreading, and invasion associated with an upregulation of PTEN (a tumor suppressor gene) and …
Placebo-controlled trial of indole-3-carbinol in the treatment of CIN.
Bell MC, Crowley-Nowick P, Bradlow HL, Sepkovic DW, Schmidt-Grimminger D, Howell P, Mayeaux EJ, Tucker A, Turbat-Herrera EA, Mathis JM. Bell MC, et al. Gynecol Oncol. 2000 Aug;78(2):123-9. doi: 10.1006/gyno.2000.5847. Gynecol Oncol. 2000. PMID: 10926790 Clinical Trial.
Estrogen metabolism and risk of breast cancer: a prospective study of the 2:16alpha-hydroxyestrone ratio in premenopausal and postmenopausal women.
Muti P, Bradlow HL, Micheli A, Krogh V, Freudenheim JL, Schünemann HJ, Stanulla M, Yang J, Sepkovic DW, Trevisan M, Berrino F. Muti P, et al. Epidemiology. 2000 Nov;11(6):635-40. doi: 10.1097/00001648-200011000-00004. Epidemiology. 2000. PMID: 11055622
Indole-3-carbinol. A novel approach to breast cancer prevention.
Bradlow HL, Sepkovic DW, Telang NT, Osborne MP. Bradlow HL, et al. Ann N Y Acad Sci. 1995 Sep 30;768:180-200. doi: 10.1111/j.1749-6632.1995.tb12121.x. Ann N Y Acad Sci. 1995. PMID: 8526347 Review.
Influence of postmenopausal hormone replacement therapy on an estrogen metabolite biomarker of risk for breast cancer.
Alvarez-Vasquez RB, Axelrod D, Frenkel K, Newman MC, Sepkovic DW, Bradlow HL, Zumoff B. Alvarez-Vasquez RB, et al. Horm Metab Res. 2003 Jun;35(6):358-61. doi: 10.1055/s-2003-41357. Horm Metab Res. 2003. PMID: 12920658
79 results
Jump to page
Feedback